Various applications of microRNAs in skin diseases

Journal of Dermatological Science

Volumn 74, Issue 1, 2014, Pages 3-8

  Jinnin, Masatoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

MicroRNA; Scleroderma; Skin

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; MESSENGER RNA; METHOTREXATE; MICRORNA; MICRORNA 125; MICRORNA 1266; MICRORNA 128A; MICRORNA 142 3P; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 181A; MICRORNA 18A 5P; MICRORNA 196A; MICRORNA 203; MICRORNA 205; MICRORNA 206; MICRORNA 21; MICRORNA 223; MICRORNA 29A; MICRORNA 29B; MICRORNA 424; MICRORNA 9; PREDNISOLONE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; MIRN150 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE MARKER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HAIR ANALYSIS; INTERACTIONS WITH RNA; KERATINOCYTE; MELANOMA; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; RNA BLOOD LEVEL; RNA STRUCTURE; SCLERODERMA; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN FIBROBLAST; SKIN FIBROSIS; TOXIC EPIDERMAL NECROLYSIS; ANIMAL; BLOOD; FIBROSIS; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SKIN DISEASES;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; SKIN DISEASES;

EID: 84895922946     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.01.004     Document Type: Review

References (49)

1. Lee R., Feinbaum R., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
3. Maragkakis M., Alexiou P., Papadopoulos G.L., Reczko M., Dalamagas T., Giannopoulos G., et al. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009, 10:295.
4. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol 2005, 3:e85.
5. Baek D., Villén J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
6. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5'UTR as in the 3'UTR. Proc Natl Acad Sci U S A 2007, 104:9667-9672.
7. Maurer B., Stanczyk J., Jüngel A., Akhmetshina A., Trenkmann M., Brock M., et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010, 62:1733-1743.
8. Honda N., Jinnin M., Kajihara I., Makino T., Makino K., Masuguchi S., et al. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. J Immunol 2012, 188:3323-3331.
9. Eisenberg I., Eran A., Nishino I., Moggio M., Lamperti C., Amato A.A., et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 2007, 104:17016-17021.
10. Inoue K., Jinnin M., Yamane K., Makino T., Kajihara I., Makino K., et al. Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCe{open}. Eur J Dermatol 2013, 23:160-167.
11. Sonkoly E., Wei T., Janson P.C., Sääf A., Lundeberg L., Tengvall-Linder M., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2007, 2:e610.
12. Sonkoly E., Ståhle M., Pivarcsi A. MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol 2008, 33:312-315.
13. Zibert J., Løvendorf M., Litman T., Olsen J., Kaczkowski B., Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010, 58:177-185.
14. Ichihara A., Jinnin M., Yamane K., Fujisawa A., Sakai K., Masuguchi S., et al. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol 2011, 165:1003-1010.
15. Ichihara A., Wang Z., Jinnin M., Izuno Y., Shimozono N., Yamane K., et al. Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions. J Allergy Clin Immunol 2014, [in press].
16. Bertino J.R., Banerjee D., Mishra P.J. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics 2007, 8:1625-1627.
17. Furer V., Greenberg J.D., Attur M., Abramson S.B., Pillinger M.H. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 2010, 136:1-15.
18. Yamashita J., Iwakiri T., Fukushima S., Jinnin M., Miyashita A., Hamasaki T., et al. The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma. Melanoma Res 2013, 23:13-20.
19. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
20. Hanke M., Hoefig K., Merz H., Feller A.C., Kausch I., Jocham D., et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010, 28:655-661.
21. Michael A., Bajracharya S.D., Yuen P.S., Zhou H., Star R.A., Illei G.G., et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010, 16:34-38.
22. Kosaka N., Izumi H., Sekine K., Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence 2010, 1:7.
23. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 2012, 3:28-37.
24. van Dommelen S.M., Vader P., Lakhal S., Kooijmans S.A., van Solinge W.W., Wood M.J., et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 2012, 161:635-644.
25. Zhang L., Hou D., Chen X., Li D., Zhu L., Zhang Y., et al. Exogenous plant miR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012, 22:107-126.
26. Kawashita Y., Jinnin M., Makino T., Kajihara I., Makino K., Honda N., et al. Circulating miR-29a levels in patients with scleroderma spectrum disorder. J Dermatol Sci 2011, 61:67-69.
27. Ihn H., Sato S., Tamaki T., Soma Y., Tsuchida T., Ishibashi Y., et al. Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 1992, 284:391-395.
28. Honda N., Jinnin M., Kira-Etoh T., Makino K., Kajihara I., Makino T., et al. miR-150 down-regulation contributes to the constitutive type i collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3. Am J Pathol 2013, 182:206-216.
29. Shimada S., Jinnin M., Ogata A., Makino T., Kajihara I., Makino K., et al. Serum miR-21 levels in patients with dermatomyositis. Clin Exp Rheumatol 2013, 31:161-162.
30. Oshikawa Y., Jinnin M., Makino T., Kajihara I., Makino K., Honda N., et al. Decreased miR-7 expression in the skin and sera of patients with dermatomyositis. Acta Derm Venereol 2013, 93:273-276.
31. Makino K., Jinnin M., Kajihara I., Honda N., Sakai K., Masuguchi S., et al. Circulating miR-142-3p levels in patients with systemic sclerosis. Clin Exp Dermatol 2012, 37:34-39.
32. Sing T., Jinnin M., Yamane K., Honda N., Makino K., Kajihara I., et al. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology 2012, 51:1550-1556.
33. Pivarcsi A., Meisgen F., Xu N., Sthle M., Sonkoly E. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. Br J Dermatol 2013, 169:563-570.
34. Ichihara A., Jinnin M., Oyama R., Yamane K., Fujisawa A., Sakai K., et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 2012, 22:68-71.
35. Li H., Yang R., Fan X., Gu T., Zhao Z., Chang D., et al. MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int 2012, 32:307-313.
36. Li H., Yang R., Fan X., Gu T., Zhao Z., Chang D., et al. MicroRNA array analysis of microRNAs related to systemic scleroderma. J Clin Immunol 2012, 32:514-522.
37. Koba S., Jinnin M., Inoue K., Nakayama W., Honda N., Makino K., et al. Expression analysis of multiple microRNAs in each patient with scleroderma. Exp Dermatol 2013, 22:489-491.
38. Shiiyama R., Fukushima S., Jinnin M., Yamashita J., Miyashita A., Nakahara S., et al. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles. Melanoma Res 2014, [in press].
39. Lefkowitz G.K., Mukhopadhyay A., Cowing-Zitron C., Yu B.D. The post-apoptotic fate of RNAs identified through high-throughput sequencing of human hair. PLoS ONE 2011, 6:e27603.
40. Wang Z., Jinnin M., Kudo H., Inoue K., Nakayama W., Honda N., et al. Detection of hair-microRNAs as the novel potent biomarker: Evaluation of the usefulness for the diagnosis of scleroderma. J Dermatol Sci 2013, 72:134-141.
41. Takemoto R., Jinnin M., Wang Z., Kudo H., Inoue K., Nakayama W., et al. Hair miR-29a levels are decreased in patients with scleroderma. Exp Dermatol 2013, 22:832-833.
42. Hirao H., Jinnin M., Ichihara A., Fujisawa A., Makino K., Kajihara I., et al. Detection of hair root miR-19a as a novel diagnostic marker for psoriasis. Eur J Dermatol 2014, [in press].
43. Kowal-Bielecka O., Landewé R., Avouac J., Chwiesko S., Miniati I., Czirjak L., et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR scleroderma trials and research group (EUSTAR). Ann Rheum Dis 2009, 68:620-628.
44. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis c virus infection. Science 2010, 327:198-201.
45. Nakasa T., Shibuya H., Nagata Y., Niimoto T., Ochi M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 2011, 63:1582-1590.
46. Ibrahim A.F., Weirauch U., Thomas M., Grünweller A., Hartmann R.K., Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011, 71:5214-5224.
47. Courboulin A., Paulin R., Giguère N.J., Saksouk N., Perreault T., Meloche J., et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011, 208:535-548.
48. Patrick D.M., Montgomery R.L., Qi X., Obad S., Kauppinen S., Hill J.A., et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010, 120:3912-3916.
49. Makino K., Jinnin M., Hirano A., Yamane K., Eto M., Kusano T., et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol 2013, 190:3905-3915.